FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111837209> ?p ?o ?g. }

• W3111837209 endingPage "6033" @default.
• W3111837209 startingPage "6023" @default.
• W3111837209 abstract "The search for biomarkers based on the mechanism of drug action has not been thoroughly addressed in the therapeutic approaches to multiple myeloma (MM), mainly because of the difficulty in analyzing proteins obtained from purified plasma cells. Here, we investigated the prognostic impact of the expression of 12 proteins involved in the mechanism of action of bortezomib, lenalidomide, and dexamethasone (VRD), quantified by capillary nanoimmunoassay, in CD138-purified samples from 174 patients with newly diagnosed MM treated according to the PETHEMA/GEM2012 study. A high level of expression of 3 out of 5 proteasome components tested (PSMD1, PSMD4, and PSMD10) negatively influenced survival. The 5 analyzed proteins involved in lenalidomide's mode of action were associated with time to progression (TTP); low levels of cereblon and IRF4 protein and high levels of Ikaros, AGO2, and Aiolos were significantly associated with shorter TTP. Although the glucocorticoid receptor (GCR) level by itself had no significant impact on MM prognosis, a high XPO1 (exportin 1)/GCR ratio was associated with shorter TTP and progression-free survival (PFS). The multivariate Cox model identified high levels of PSMD10 (hazard ratio [HR] TTP, 3.49; P = .036; HR PFS, 5.33; P = .004) and Ikaros (HR TTP, 3.01, P = .014; HR PFS, 2.57; P = .028), and low levels of IRF4 protein expression (HR TTP, 0.33; P = .004; HR PFS, 0.35; P = .004) along with high-risk cytogenetics (HR TTP, 3.13; P < .001; HR PFS, 2.69; P = .002), as independently associated with shorter TTP and PFS. These results highlight the value of assessing proteins related to the mechanism of action of drugs used in MM for predicting treatment outcome." @default.
• W3111837209 created "2020-12-21" @default.
• W3111837209 creator A5000193525 @default.
• W3111837209 creator A5004453681 @default.
• W3111837209 creator A5010614170 @default.
• W3111837209 creator A5015898454 @default.
• W3111837209 creator A5020420490 @default.
• W3111837209 creator A5020989412 @default.
• W3111837209 creator A5025023747 @default.
• W3111837209 creator A5031837957 @default.
• W3111837209 creator A5034182883 @default.
• W3111837209 creator A5042146212 @default.
• W3111837209 creator A5047866471 @default.
• W3111837209 creator A5054952877 @default.
• W3111837209 creator A5054984393 @default.
• W3111837209 creator A5059482051 @default.
• W3111837209 creator A5079627421 @default.
• W3111837209 date "2020-12-07" @default.
• W3111837209 modified "2023-10-18" @default.
• W3111837209 title "Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma" @default.
• W3111837209 cites W1537559901 @default.
• W3111837209 cites W1544853593 @default.
• W3111837209 cites W1550062580 @default.
• W3111837209 cites W1555729280 @default.
• W3111837209 cites W1933138417 @default.
• W3111837209 cites W1970537520 @default.
• W3111837209 cites W1981403111 @default.
• W3111837209 cites W1986412656 @default.
• W3111837209 cites W1988265934 @default.
• W3111837209 cites W1993469143 @default.
• W3111837209 cites W1997952190 @default.
• W3111837209 cites W1999549312 @default.
• W3111837209 cites W2007638982 @default.
• W3111837209 cites W2008250750 @default.
• W3111837209 cites W2009386327 @default.
• W3111837209 cites W2015345028 @default.
• W3111837209 cites W2029690067 @default.
• W3111837209 cites W2032640560 @default.
• W3111837209 cites W2035145745 @default.
• W3111837209 cites W2041390166 @default.
• W3111837209 cites W2041694372 @default.
• W3111837209 cites W2050345955 @default.
• W3111837209 cites W2051550400 @default.
• W3111837209 cites W2070506594 @default.
• W3111837209 cites W2073817882 @default.
• W3111837209 cites W2076744879 @default.
• W3111837209 cites W2077682572 @default.
• W3111837209 cites W2083750690 @default.
• W3111837209 cites W2094465405 @default.
• W3111837209 cites W2099395323 @default.
• W3111837209 cites W2112058277 @default.
• W3111837209 cites W2112064435 @default.
• W3111837209 cites W2119717274 @default.
• W3111837209 cites W2126170617 @default.
• W3111837209 cites W2128192762 @default.
• W3111837209 cites W2138247679 @default.
• W3111837209 cites W2158228898 @default.
• W3111837209 cites W2163406684 @default.
• W3111837209 cites W2175072810 @default.
• W3111837209 cites W2187468410 @default.
• W3111837209 cites W2319571985 @default.
• W3111837209 cites W2345701890 @default.
• W3111837209 cites W2434407168 @default.
• W3111837209 cites W2564000840 @default.
• W3111837209 cites W2604776612 @default.
• W3111837209 cites W2772881286 @default.
• W3111837209 cites W2774700270 @default.
• W3111837209 cites W2793369944 @default.
• W3111837209 cites W2800882200 @default.
• W3111837209 cites W2888932978 @default.
• W3111837209 cites W2897241170 @default.
• W3111837209 cites W2912230672 @default.
• W3111837209 cites W2914257148 @default.
• W3111837209 cites W2951474203 @default.
• W3111837209 doi "https://doi.org/10.1182/bloodadvances.2020002711" @default.
• W3111837209 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7724915" @default.
• W3111837209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33284947" @default.
• W3111837209 hasPublicationYear "2020" @default.
• W3111837209 type Work @default.
• W3111837209 sameAs 3111837209 @default.
• W3111837209 citedByCount "14" @default.
• W3111837209 countsByYear W31118372092021 @default.
• W3111837209 countsByYear W31118372092022 @default.
• W3111837209 countsByYear W31118372092023 @default.
• W3111837209 crossrefType "journal-article" @default.
• W3111837209 hasAuthorship W3111837209A5000193525 @default.
• W3111837209 hasAuthorship W3111837209A5004453681 @default.
• W3111837209 hasAuthorship W3111837209A5010614170 @default.
• W3111837209 hasAuthorship W3111837209A5015898454 @default.
• W3111837209 hasAuthorship W3111837209A5020420490 @default.
• W3111837209 hasAuthorship W3111837209A5020989412 @default.
• W3111837209 hasAuthorship W3111837209A5025023747 @default.
• W3111837209 hasAuthorship W3111837209A5031837957 @default.
• W3111837209 hasAuthorship W3111837209A5034182883 @default.
• W3111837209 hasAuthorship W3111837209A5042146212 @default.
• W3111837209 hasAuthorship W3111837209A5047866471 @default.
• W3111837209 hasAuthorship W3111837209A5054952877 @default.
• W3111837209 hasAuthorship W3111837209A5054984393 @default.

• next